Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-6-23
pubmed:abstractText
Antigen-specific immunotherapy is expected to be an ideal strategy for treating type 1 diabetes (T1D). We investigated the therapeutic efficacy of a peptide in the leader sequence of preproinsulin, which was selected because of its binding affinity to the MHC I-A(g7) molecule. Preproinsulin-1 L7-24 peptide (L7-24) emulsified in Freund's incomplete adjuvant was administered subcutaneously to NOD mice. Administration of L7-24 increased the proportion of regulatory T cells in the spleen. Splenocytes of NOD mice immunized with this peptide secreted IL-4 and IL-10 in response to L7-24. This peptide also significantly prevented the development of diabetes and cured some newly diabetic NOD mice without recurrence. L7-24 peptide, which has a high affinity for pockets of I-A(g7), induced regulatory T cells and showed therapeutic effects. This peptide may provide a new approach for developing antigen-specific immunotherapy for autoimmune diabetes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Concanavalin A, http://linkedlifedata.com/resource/pubmed/chemical/Forkhead Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/Foxp3 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Protein Precursors, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta, http://linkedlifedata.com/resource/pubmed/chemical/preproinsulin
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1521-7035
pubmed:author
pubmed:copyrightInfo
(c) 2010 Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
136
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
74-82
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:20359955-Amino Acid Sequence, pubmed-meshheading:20359955-Animals, pubmed-meshheading:20359955-Autoimmunity, pubmed-meshheading:20359955-Blood Glucose, pubmed-meshheading:20359955-Cell Count, pubmed-meshheading:20359955-Concanavalin A, pubmed-meshheading:20359955-Diabetes Mellitus, Type 1, pubmed-meshheading:20359955-Female, pubmed-meshheading:20359955-Forkhead Transcription Factors, pubmed-meshheading:20359955-Histocompatibility Antigens Class II, pubmed-meshheading:20359955-Immunotherapy, Active, pubmed-meshheading:20359955-Insulin, pubmed-meshheading:20359955-Interferon-gamma, pubmed-meshheading:20359955-Interleukin-10, pubmed-meshheading:20359955-Interleukin-4, pubmed-meshheading:20359955-Islets of Langerhans, pubmed-meshheading:20359955-Lymphocyte Activation, pubmed-meshheading:20359955-Mice, pubmed-meshheading:20359955-Mice, Inbred NOD, pubmed-meshheading:20359955-Mice, Knockout, pubmed-meshheading:20359955-Peptide Fragments, pubmed-meshheading:20359955-Protein Binding, pubmed-meshheading:20359955-Protein Precursors, pubmed-meshheading:20359955-Spleen, pubmed-meshheading:20359955-T-Lymphocytes, pubmed-meshheading:20359955-T-Lymphocytes, Regulatory, pubmed-meshheading:20359955-Th2 Cells, pubmed-meshheading:20359955-Transforming Growth Factor beta, pubmed-meshheading:20359955-Vaccination
pubmed:year
2010
pubmed:articleTitle
Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
pubmed:affiliation
Department of Internal and Geriatric Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
pubmed:publicationType
Journal Article